Annual general meeting and evidence session
EDITED: 11/10/2017 | PUBLISHED: 07/07/2017
The All-Party Parliamentary Group on Personalised Medicine began its work programme for the new parliamentary team with an annual general meeting and the first evidence session of its inquiry on personalised medicine in cardiovascular disease. Both were held at Milbank House on Wednesday 12 July.
A major health concern in the UK, cardiovascular (heart and circulatory) disease accounts for over a quarter of all UK deaths and costs the UK economy about £19 billion every year. Consequently, the APPG members have opted to carry out an inquiry exploring the potential of personalised medicine to improve patient care and health outcomes for those suffering from this disease.
Presenting evidence at this initial meeting were Prof Perry Elliott (Chair of Cardiovascular Medicine, University College London; Consultant Cardiologist, Barts Heart Centre; President, Cardiomyopathy UK) and Prof Jeremy Parson (Associate Medical Director (Research) at the British Heart Foundation; Emeritus Professor of Vascular Biology at King's College London).
The meeting concluded with a Q&A where parliamentarians posed questions to the experts regarding key obstacles to tackling cardiovascular disease and the potential benefits of more personalised medicine.
Following the meeting the APPG on Personed Medicine held their AGM, which was led by new Chair Helen Whately MP.
Minutes from this important discussion are available here.